Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? an analysis of data from the national epidemiologic survey on alcohol and related conditions (NESARC)

Journal of Clinical Psychiatry

Volumn 75, Issue 3, 2014, Pages 231-237

  Hoertel, Nicolas ^a   Falissard, Bruno ^a   Humphreys, Keith ^a   Gorwood, Philip ^a   Seigneurie, Anne Sophie ^a   Limosin, Frederic ^a  

^a Paris Descartes University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DYSTHYMIA; GENERALIZED ANXIETY DISORDER; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MANIA; MOOD DISORDER; PANIC; PHOBIA; PRIORITY JOURNAL; RESEARCH SUBJECT; SOCIAL PHOBIA;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANXIETY DISORDERS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PATIENT SELECTION; UNITED STATES; YOUNG ADULT;

EID: 84898743160     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08424     Document Type: Article

References (38)

1. Blanco C, Olfson M, Goodwin RD, et al. Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Clin Psychiatry. 2008;69(8):1276-1280.
2. Hoertel N, Le Strat Y, De Maricourt P, et al. Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? results from a national sample. Affect Disord. 2013;146(3):383-389.
3. Hoertel N, Le Strat Y, Lavaud P, et al. Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Clin Psychiatry. 2013;74(3):265-270.
4. Hoertel N, Le Strat Y, Limosin F, et al. Prevalence of subthreshold hypomania and impact on internal validity of RCTs for major depressive disorder: results from a national epidemiological sample. PLoS ONE. 2013;8(2):e55448.
5. Dzewaltowski DA, Estabrooks PA, Klesges LM, et al. Behavior change intervention research in community settings: how generalizable are the results? Health Promotlnt. 2004;19(2):235-245.
6. Hoertel N, Le Strat Y, Angst J, et al. Subthreshold bipolar disorder in a US national representative sample: prevalence, correlates and perspectives for psychiatric nosography. J Affect Disord. 2013;146(3):338-347.
7. Humphreys K, Weingardt KR, Horst D, et al. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction. 2005;100(9):1249-1257.
8. Blanco C, Olfson M, Okuda M, et al. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend. 2008;98(1-2):123-128.
9. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233-1240.
10. Humphreys K, Harris AH, Weingardt KR. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol Drugs. 2008;69(5):757-764.
11. Humphreys K, Weingardt KR, Harris AH. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res. 2007;31(6):988-995.
12. Humphreys K, Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J. Psychiatry. 2000;157(4):588-594.
13. March JS, Silva SG, Compton S, et al. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162(5):836-846.
14. Haver B. Comorbid psychiatric disorders predict and influence treatment outcome in female alcoholics. Eur Addict Res. 2003;9(1):39-44.
15. McLellan AT, Luborsky L, Woody GE, et al. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983;40(6):620-625.
16. Stoffelmayr BE, Benishek LA, Humphreys K, et al. Substance abuse prognosis with an additional psychiatric diagnosis: understanding the relationship. J Psychoactive Drugs. 1989;21(2):145-152.
17. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816.
18. Hasin D, LiuX, Nunes E, et al. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380.
19. Roy-Byrne PP, Stang P, Wittchen HU, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. BrJ Psychiatry. 2000;176(3):229-235.
20. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. Occup Environ Med. 2003;45(1):5-14.
21. Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv. 2002;53(1):80-86.
22. Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135-3144.
23. Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37-44.
24. Grant BF, Dawson DA, Stinson FS, et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004;74(3):223-234.
25. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7-16.
26. Chatterji S, Saunders JB, Vrasti R, et al. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule-Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47(3):171-185.
27. Hasin D, Carpenter KM, McCloud S, et al. The Alcohol Use Disorder and Associated Disabilities Interview Ichedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2-3):133-141.
28. Canino G, Bravo M, Ramirez R, et al. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. Stud Alcohol. 1999;60(6):790-799.
29. Cottier LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195-205.
30. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106.
31. Monahan SC, Finney JW Explaining abstinence rates fo11owing treatment for alcohol abuse: a quantitative synthesis of patient, research design and treatment effects. Addiction. 1996;91(6):787-805.
32. Le Strat Y, Hoertel N. Correlation is no causation: gymnasium proliferation and the risk of obesity. Addiction. 2011;106(10):1871-1872.
33. Melberg HO, Humphreys K. Ineligibility and refusal to participate in randomised trials of treatments for drug dependence. Drug Alcohol Rev Mar. 2010;29(2):193-201.
34. Mavissakalian MR, Guo S. Predictors of entering a long-term drug treatment study of panic disorder. Compr Psychiatry. 2002;43(2):88-94.
35. Humphreys K, Maisel NC, Blodgett JC, et al. Extent and reporting of patient nonenro11ment in influential randomized clinical trials, 2002 to 2010. JAMA Intern Med. 2013;173(11):1029-1031.
36. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet. 2005;365(9453):82-93.
37. Hoertel N, Le Strat Y, Blanco C, et al. Generalizability of clinical trial results for generalized anxiety disorder to community samples. Depress Anxiety. 2012;29(7):614-620.
38. Geddes JR. Large simple trials in psychiatry: providing reliable answers to important clinical questions. Epidemiol Psichiatr Soc. 2005;14(3):122-126.